Transamerica Financial Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-232
| Closed | -$33K | – | 734 |
|
|
2016
Q1 | $33K | Sell |
232
-28
| -11% | -$3.98K | ﹤0.01% | 426 |
|
|
2015
Q4 | $50K | Hold |
260
| – | – | ﹤0.01% | 408 |
|
|
2015
Q3 | $41K | Hold |
260
| – | – | ﹤0.01% | 408 |
|
|
2015
Q2 | $48K | Sell |
260
-32
| -11% | -$5.91K | ﹤0.01% | 462 |
|
|
2015
Q1 | $51K | Buy |
292
+32
| +12% | +$5.59K | ﹤0.01% | 437 |
|
|
2014
Q4 | $49K | Sell |
260
-93
| -26% | -$17.5K | ﹤0.01% | 364 |
|
|
2014
Q3 | $59K | Sell |
353
-2,884
| -89% | -$482K | 0.01% | 332 |
|
|
2014
Q2 | $507K | Buy |
3,237
+223
| +7% | +$34.9K | 0.04% | 177 |
|
|
2014
Q1 | $459K | Sell |
3,014
-18
| -0.6% | -$2.74K | 0.05% | 170 |
|
|
2013
Q4 | $403K | Sell |
3,032
-225
| -7% | -$29.9K | 0.04% | 177 |
|
|
2013
Q3 | $379K | Buy |
+3,257
| New | +$379K | 0.05% | 163 |
|